世界の放射線腫瘍治療市場2020年-2027年:種類別(外部照射放射線治療、内部照射放射線治療)、用途別(前立腺がん、乳がん、肺がん、頭頸部がん、結腸直腸がん、子宮頸がん、婦人科がん、その他)、地域別

■ 英語タイトル:Radiation Oncology Market by Type (External Beam Radiation Therapy and Internal Beam Radiation Therapy), Application (Prostate Cancer, Breast Cancer, Lung Cancer, Head & Neck Cancer, Colorectal Cancer, Cervical Cancer, Gynecological Cancer, and Others), and Regional Analysis (North America, Europe, Asia-Pacific, and LAMEA): Global Opportunity Analysis and Industry Forecast, 2020–2027

調査会社Research Dive|世界社が発行したリサーチレポート(データ管理コード:RDV21MC019)■ 発行会社/調査会社:Research Dive|世界
■ 商品コード:RDV21MC019
■ 発行日:2021年2月
■ 調査対象地域:グローバル
■ 産業分野:ライフサイエンス
■ ページ数:248
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール
■ 販売価格オプション(消費税別)
Single User License USD4,250 ⇒換算¥629,000見積依頼/購入/質問フォーム
5 User LicenseUSD5,750 ⇒換算¥851,000見積依頼/購入/質問フォーム
Enterprise User LicenseUSD6,250 ⇒換算¥925,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
Research Dive|世界社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[世界の放射線腫瘍治療市場2020年-2027年:種類別(外部照射放射線治療、内部照射放射線治療)、用途別(前立腺がん、乳がん、肺がん、頭頸部がん、結腸直腸がん、子宮頸がん、婦人科がん、その他)、地域別]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

Research Dive社の本調査レポートは、世界の放射線腫瘍治療市場について調査し、調査手法、エグゼクティブサマリー、市場概要、種類別(外部照射放射線治療、内部照射放射線治療)分析、用途別(前立腺がん、乳がん、肺がん、頭頸部がん、結腸直腸がん、その他)分析、地域別分析、企業情報などを掲載しています。
・調査手法
・エグゼクティブサマリー
・市場概要
・世界の放射線腫瘍治療市場規模:種類別(外部照射放射線治療、内部照射放射線治療)
・世界の放射線腫瘍治療市場規模:用途別(前立腺がん、乳がん、肺がん、頭頸部がん、結腸直腸がん、その他)
・世界の放射線腫瘍治療市場規模:地域別
・企業情報

The global radiation oncology market accounted for $6,820.6 million in 2019; it is anticipated to generate a revenue of $10,679.7 million by 2027 at a 7.4% CAGR, according to Research Dive.
The COVID-19 pandemic has had a negative impact on the global radiation oncology market growth in 2020. During this epidemic time, many of the healthcare professionals have experienced disruption in medical devices supply chains due to global lockdown. However, some of the key participants are implementing several tactics such as collaborations and agreements to sustain during the crisis. For instance, in June 2020, Isoray and the University of Cincinnati Physicians made a research agreement to study and advance the treatment procedures involved in head & neck cancers. This aspect is estimated to have significant impact on technological development in radiotherapy and is expected to drive the growth of the market during the pandemic.

The global radiation oncology market growth is significantly driven by the rising cancer prevalence and technological advancements because market leaders and healthcare professionals’ investments on R&D of radiotherapy procedures. According to American Institute of Cancer Research estimates, by 2030, about 25 million cases are estimated to diagnosed and screened ever year. This aspect is estimated to increased demand for radiotherapy due to its efficacy. Moreover, the technology and treatment procedures are constantly improving in radiation therapy like stereotactic radiotherapy and 3D conformal radiotherapy. These therapies involve less side effects and high cure rate, which is estimated to impel the industry growth in the review time. Nevertheless, lack of skilled professionals particularly in low-income countries and adverse effects related to radiation oncology techniques is estimated to limit the industry growth in the analysis time.
The global radiation oncology market is categorized into type, application, and region.
Based on type, the market is classified into internal beam radiation and external beam radiation. Among these, external beam radiation therapy sub-segment was the major revenue contributor to the overall market in the previous years and predicted to grow at a healthy CAGR of 8.3% during the forecast timeframe.

Based on application, the market is classified into breast cancer, head & neck cancer, gynecological cancer, cervical cancer, prostate cancer, lung cancer, colorectal cancer and others. Among these, breast cancer sub-segment was the largest contributor to the overall market, with $1,801.1 million in 2019 and is expected to grow at a notable rate during the review time. Prostate cancer is estimated to experience a noteworthy growth and is anticipated to generate a revenue of $870.5 million by 2027.
Geographically, the global radiation oncology market was investigated across regions such as North America, Europe, Asia-Pacific and LAMEA. Among these, North America was the highest revenue contributor, accounting to $2,981.3 million in 2019 and is anticipated to continue its dominance during the analysis time. Asia-Pacific region is estimated to have a lucrative market and is predicted to rise at a remarkable rate of 9.0% CAGR during the forecast period.
The key manufacturers in the global radiation oncology market include. Panacea Medical Technologies Pvt. Ltd., Provision Healthcare, Isoray Inc., BD, Nordion (Canada) Inc., IBA Worldwide, Mevion Medical Systems, Accuray Incorporated, Elekta AB, and Varian Medical Systems, Inc. The major participants are constantly stressing on product advancements and partnerships to increase their share over the global marketplace.

*** レポート目次(コンテンツ)***

1.Research Methodology

1.1.Desk Research
1.2.Real time insights and validation
1.3.Forecast model
1.4.Assumptions and forecast parameters

1.4.1.Assumptions
1.4.2.Forecast parameters

1.5.Data sources

1.5.1.Primary
1.5.2.Secondary

2.Executive Summary

2.1.360° summary
2.2.Type trends
2.3.Application trends

3.Market overview

3.1.Market segmentation & definitions
3.2.Key takeaways
3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.3.Porter’s five forces analysis

3.3.1.Bargaining power of consumers
3.3.2.Bargaining power of suppliers
3.3.3.Threat of new entrants
3.3.4.Threat of substitutes
3.3.5.Competitive rivalry in the market

3.4.Market dynamics

3.4.1.Drivers
3.4.2.Restraints
3.4.3.Opportunities
3.5.Technology landscape
3.6.Regulatory landscape
3.7.Patent landscape
3.8.Strategic overview

4.Radiation Oncology Market, by Type

4.1.Internal Beam Radiation Therapy

4.1.1.Market size and forecast, by region, 2019-2027
4.1.2.Comparative market share analysis, 2019 & 2027

4.2.External Beam Radiation Therapy

4.2.1.Market size and forecast, by region, 2019-2027
4.2.2.Comparative market share analysis, 2019 & 2027

5.Radiation Oncology Market, by Application

5.1.Prostate Cancer

5.1.1.Market size and forecast, by region, 2019-2027
5.1.2.Comparative market share analysis, 2019 & 2027

5.2.Breast Cancer

5.2.1.Market size and forecast, by region, 2019-2027
5.2.2.Comparative market share analysis, 2019 & 2027

5.3.Lung Cancer

5.3.1.Market size and forecast, by region, 2019-2027
5.3.2.Comparative market share analysis, 2019 & 2027

5.4.Head & Neck Cancer

5.4.1.Market size and forecast, by region, 2019-2027
5.4.2.Comparative market share analysis, 2019 & 2027

5.5.Colorectal Cancer

5.5.1.Market size and forecast, by region, 2019-2027
5.5.2.Comparative market share analysis, 2019 & 2027

5.6.Cervical Cancer

5.6.1.Market size and forecast, by region, 2019-2027
5.6.2.Comparative market share analysis, 2019 & 2027

5.7.Gynecological Cancer

5.7.1.Market size and forecast, by region, 2019-2027
5.7.2.Comparative market share analysis, 2019 & 2027

5.8.Others

5.8.1.Market size and forecast, by region, 2019-2027
5.8.2.Comparative market share analysis, 2019 & 2027

6.Radiation Oncology Market, by Region

6.1.North America

6.1.1.Market size and forecast, by type, 2019-2027
6.1.2.Market size and forecast, by application, 2019-2027
6.1.3.Market size and forecast, by country, 2019-2027
6.1.4.Comparative market share analysis, 2019 & 2027
6.1.5.U.S.

6.1.5.1.Market size and forecast, by type, 2019-2027
6.1.5.2.Market size and forecast, by application, 2019-2027
6.1.5.3.Comparative market share analysis, 2019 & 2027

6.1.6.Canada

6.1.6.1.Market size and forecast, by type, 2019-2027
6.1.6.2.Market size and forecast, by application, 2019-2027
6.1.6.3.Comparative market share analysis, 2019 & 2027

6.1.7.Mexico

6.1.7.1.Market size and forecast, by type, 2019-2027
6.1.7.2.Market size and forecast, by application, 2019-2027
6.1.7.3.Comparative market share analysis, 2019 & 2027

6.2.Europe

6.2.1.Market size and forecast, by type, 2019-2027
6.2.2.Market size and forecast, by application, 2019-2027
6.2.3.Market size and forecast, by country, 2019-2027
6.2.4.Comparative market share analysis, 2019 & 2027
6.2.5.Germany

6.2.5.1.Market size and forecast, by type, 2019-2027
6.2.5.2.Market size and forecast, by application, 2019-2027
6.2.5.3.Comparative market share analysis, 2019 & 2027

6.2.6.UK

6.2.6.1.Market size and forecast, by type, 2019-2027
6.2.6.2.Market size and forecast, by application, 2019-2027
6.2.6.3.Comparative market share analysis, 2019 & 2027

6.2.7.France

6.2.7.1.Market size and forecast, by type, 2019-2027
6.2.7.2.Market size and forecast, by application, 2019-2027
6.2.7.3.Comparative market share analysis, 2019 & 2027

6.2.8.Spain

6.2.8.1.Market size and forecast, by type, 2019-2027
6.2.8.2.Market size and forecast, by application, 2019-2027
6.2.8.3.Comparative market share analysis, 2019 & 2027

6.2.9.Italy

6.2.9.1.Market size and forecast, by type, 2019-2027
6.2.9.2.Market size and forecast, by application, 2019-2027
6.2.9.3.Comparative market share analysis, 2019 & 2027

6.2.10.Rest of Europe

6.2.10.1.Market size and forecast, by type, 2019-2027
6.2.10.2.Market size and forecast, by application, 2019-2027
6.2.10.3.Comparative market share analysis, 2019 & 2027

6.3.Asia Pacific

6.3.1.Market size and forecast, by type, 2019-2027
6.3.2.Market size and forecast, by application, 2019-2027
6.3.3.Market size and forecast, by country, 2019-2027
6.3.4.Comparative market share analysis, 2019 & 2027

6.3.5.China

6.3.5.1.Market size and forecast, by type, 2019-2027
6.3.5.2.Market size and forecast, by application, 2019-2027
6.3.5.3.Comparative market share analysis, 2019 & 2027

6.3.6.India

6.3.6.1.Market size and forecast, by type, 2019-2027
6.3.6.2.Market size and forecast, by application, 2019-2027
6.3.6.3.Comparative market share analysis, 2019 & 2027

6.3.7.Japan

6.3.7.1.Market size and forecast, by type, 2019-2027
6.3.7.2.Market size and forecast, by application, 2019-2027
6.3.7.3.Comparative market share analysis, 2019 & 2027

6.3.8.Australia

6.3.8.1.Market size and forecast, by type, 2019-2027
6.3.8.2.Market size and forecast, by application, 2019-2027
6.3.8.3.Comparative market share analysis, 2019 & 2027

6.3.9.South Korea

6.3.9.1.Market size and forecast, by type, 2019-2027
6.3.9.2.Market size and forecast, by application, 2019-2027
6.3.9.3.Comparative market share analysis, 2019 & 2027

6.3.10.Rest of Asia Pacific

6.3.10.1.Market size and forecast, by type, 2019-2027
6.3.10.2.Market size and forecast, by application, 2019-2027
6.3.10.3.Comparative market share analysis, 2019 & 2027

6.4.LAMEA

6.4.1.Market size and forecast, by type, 2019-2027
6.4.2.Market size and forecast, by application, 2019-2027
6.4.3.Market size and forecast, by country, 2019-2027
6.4.4.Comparative market share analysis, 2019 & 2027
6.4.5.Latin America

6.4.5.1.Market size and forecast, by type, 2019-2027
6.4.5.2.Market size and forecast, by application, 2019-2027
6.4.5.3.Comparative market share analysis, 2019 & 2027

6.4.6.Middle East

6.4.6.1.Market size and forecast, by type, 2019-2027
6.4.6.2.Market size and forecast, by application, 2019-2027
6.4.6.3.Comparative market share analysis, 2019 & 2027

6.4.7.Africa

6.4.7.1.Market size and forecast, by type, 2019-2027
6.4.7.2.Market size and forecast, by application, 2019-2027
6.4.7.3.Comparative market share analysis, 2019 & 2027

7.Company profiles

7.1.Varian Medical Systems, Inc.

7.1.1.Business overview
7.1.2.Financial performance
7.1.3.Product portfolio
7.1.4.Recent strategic moves & developments
7.1.5.SWOT analysis

7.2.Elekta AB

7.2.1.Business overview
7.2.2.Financial performance
7.2.3.Product portfolio
7.2.4.Recent strategic moves & developments
7.2.5.SWOT analysis

7.3.Accuray Incorporated

7.3.1.Business overview
7.3.2.Financial performance
7.3.3.Product portfolio
7.3.4.Recent strategic moves & developments
7.3.5.SWOT analysis

7.4.Mevion Medical Systems

7.4.1.Business overview
7.4.2.Financial performance
7.4.3.Product portfolio
7.4.4.Recent strategic moves & developments
7.4.5.SWOT analysis

7.5.IBA Worldwide

7.5.1.Business overview
7.5.2.Financial performance
7.5.3.Product portfolio
7.5.4.Recent strategic moves & developments
7.5.5.SWOT analysis

7.6.Nordion (Canada) Inc.

7.6.1.Business overview
7.6.2.Financial performance
7.6.3.Product portfolio
7.6.4.Recent strategic moves & developments
7.6.5.SWOT analysis

7.7.BD

7.7.1.Business overview
7.7.2.Financial performance
7.7.3.Product portfolio
7.7.4.Recent strategic moves & developments
7.7.5.SWOT analysis

7.8.Isoray Inc.

7.8.1.Business overview
7.8.2.Financial performance
7.8.3.Product portfolio
7.8.4.Recent strategic moves & developments
7.8.5.SWOT analysis

7.9.Provision Healthcare

7.9.1.Business overview
7.9.2.Financial performance
7.9.3.Product portfolio
7.9.4.Recent strategic moves & developments
7.9.5.SWOT analysis

7.10.Panacea Medical Technologies Pvt. Ltd

7.10.1.Business overview
7.10.2.Financial performance
7.10.3.Product portfolio
7.10.4.Recent strategic moves & developments
7.10.5.SWOT analysis



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(RDV21MC019 )"世界の放射線腫瘍治療市場2020年-2027年:種類別(外部照射放射線治療、内部照射放射線治療)、用途別(前立腺がん、乳がん、肺がん、頭頸部がん、結腸直腸がん、子宮頸がん、婦人科がん、その他)、地域別" (英文:Radiation Oncology Market by Type (External Beam Radiation Therapy and Internal Beam Radiation Therapy), Application (Prostate Cancer, Breast Cancer, Lung Cancer, Head & Neck Cancer, Colorectal Cancer, Cervical Cancer, Gynecological Cancer, and Others), and Regional Analysis (North America, Europe, Asia-Pacific, and LAMEA): Global Opportunity Analysis and Industry Forecast, 2020–2027)はResearch Dive|世界社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。